Mark Selby

14.3k total citations · 2 hit papers
96 papers, 9.6k citations indexed

About

Mark Selby is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Mark Selby has authored 96 papers receiving a total of 9.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 21 papers in Oncology and 20 papers in Molecular Biology. Recurrent topics in Mark Selby's work include Cancer Immunotherapy and Biomarkers (16 papers), Advancements in Solid Oxide Fuel Cells (15 papers) and Hepatitis C virus research (15 papers). Mark Selby is often cited by papers focused on Cancer Immunotherapy and Biomarkers (16 papers), Advancements in Solid Oxide Fuel Cells (15 papers) and Hepatitis C virus research (15 papers). Mark Selby collaborates with scholars based in United States, United Kingdom and Japan. Mark Selby's co-authors include William J. Rutter, Alan J. Korman, Graeme I. Bell, Changyu Wang, Michael Houghton, Charles G. Drake, Robert H. Edwards, Robert A. Anders, Alice Pons and William H. Sharfman and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Mark Selby

92 papers receiving 9.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates

2010 2.3k citations Changyu Wang, Mark Selby et al. profile →
In Vitro Characterization of the Anti-PD-1 Antibody Nivolumab, BMS-936558, and In Vivo Toxicology in Non-Human Primates

2014 472 citations Changyu Wang, Kent Thudium et al. Cancer Immunology Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Selby United States	42	3.4k	3.2k	3.0k	1.3k	1.3k	96	9.6k
Fernando Arenzana‐Seisdedos France	58	6.3k 1.8×	7.1k 2.2×	5.0k 1.7×	1.6k 1.2×	674 0.5×	93	16.9k
Thomas Bugge United States	62	1.9k 0.6×	1.6k 0.5×	4.5k 1.5×	828 0.6×	668 0.5×	165	11.2k
Masahiko Kuroda Japan	47	2.3k 0.7×	2.2k 0.7×	7.1k 2.4×	1.2k 0.9×	365 0.3×	228	12.2k
Hanswalter Zentgraf Germany	68	2.0k 0.6×	1.4k 0.4×	7.9k 2.6×	2.5k 1.9×	781 0.6×	226	14.1k
David Buck United Kingdom	37	2.5k 0.7×	3.0k 0.9×	3.7k 1.2×	558 0.4×	167 0.1×	66	9.1k
Shoshana Levy United States	60	1.3k 0.4×	4.3k 1.3×	3.9k 1.3×	1.7k 1.3×	2.2k 1.7×	137	11.3k
Arie Abo United States	41	4.3k 1.3×	2.6k 0.8×	8.7k 2.9×	394 0.3×	449 0.3×	56	15.1k
Stephen C. Peiper United States	59	4.2k 1.2×	6.6k 2.1×	4.3k 1.4×	1.2k 0.9×	216 0.2×	178	14.1k
Victor Koteliansky United States	57	1.8k 0.5×	3.0k 0.9×	10.3k 3.4×	1.7k 1.2×	897 0.7×	125	17.2k
Hamid Band United States	60	3.0k 0.9×	4.0k 1.2×	6.1k 2.0×	673 0.5×	242 0.2×	199	11.4k

Countries citing papers authored by Mark Selby

Since Specialization

Citations

This map shows the geographic impact of Mark Selby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Selby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Selby more than expected).

Fields of papers citing papers by Mark Selby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Selby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Selby. The network helps show where Mark Selby may publish in the future.

Co-authorship network of co-authors of Mark Selby

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Selby. A scholar is included among the top collaborators of Mark Selby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Selby. Mark Selby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fesen, Robert A., Daniel Patnaude, Wei-Hao Wang, et al.. (2025). Deep Optical Images of the Ejecta Nebula around the Wolf–Rayet Star WR 8 (HD 62910). The Astronomical Journal. 169(4). 231–231. 1 indexed citations

Selby, Mark, et al.. (2024). Abstract 5243: CAR B cells to accelerate antigen presentation in cancer. Cancer Research. 84(6_Supplement). 5243–5243.

Thudium, Kent, Mark Selby, Julie A. Zorn, et al.. (2022). Preclinical Characterization of Relatlimab, a Human LAG-3–Blocking Antibody, Alone or in Combination with Nivolumab. Cancer Immunology Research. 10(10). 1175–1189. 55 indexed citations

McDonald, Bryan, Nathan O. Siemers, Mark Selby, et al.. (2021). Fc-Optimized Anti-CCR8 Antibody Depletes Regulatory T Cells in Human Tumor Models. Cancer Research. 81(11). 2983–2994. 76 indexed citations

Hjalmarsson, Per, et al.. (2021). 1MW-Class Solid Oxide Electrolyser System Prototype for Low-Cost Green Hydrogen. ECS Transactions. 103(1). 383–392. 11 indexed citations

Leah, Robert, et al.. (2021). Lifetime Prediction and Rapid Design Evaluation of SteelCell^® Stacks Using Advanced Multiphysics Modeling. ECS Transactions. 103(1). 727–737.

Selby, Mark, et al.. (2019). <p>Aryl hydrocarbon receptor acts as a tumor suppressor in a syngeneic MC38 colon carcinoma tumor model</p>. PubMed. Volume 7. 1–16. 12 indexed citations

Sidney, John, et al.. (2019). Identification of epitopes in ovalbumin that provide insights for cancer neoepitopes. JCI Insight. 4(8). 18 indexed citations

Leah, Robert, Ahmet Selçuk, Mahfujur Rahman, et al.. (2017). Development Progress on the Ceres Power Steel Cell Technology Platform: Further Progress Towards Commercialization. ECS Meeting Abstracts. MA2017-03(1). 7–7. 2 indexed citations

10.

Wang, Changyu, Kent Thudium, Minhua Han, et al.. (2014). In Vitro Characterization of the Anti-PD-1 Antibody Nivolumab, BMS-936558, and In Vivo Toxicology in Non-Human Primates. Cancer Immunology Research. 2(9). 846–856. 472 indexed citations breakdown →

11.

Korman, Alan J., Bing Chen, Changyu Wang, et al.. (2007). Activity of Anti-PD-1 in Murine Tumor Models: Role of “Host” PD-L1 and Synergistic Effect of Anti-PD-1 and Anti-CTLA-4 (48.37). The Journal of Immunology. 178(1_Supplement). S82–S82. 40 indexed citations

12.

Polakos, Noelle K., Debbie Drane, John C. Cox, et al.. (2001). Characterization of Hepatitis C Virus Core-Specific Immune Responses Primed in Rhesus Macaques by a Nonclassical ISCOM Vaccine. The Journal of Immunology. 166(5). 3589–3598. 75 indexed citations

13.

Widera, Georg, Melissa A. Austin, Dietmar Rabussay, et al.. (2000). Increased DNA Vaccine Delivery and Immunogenicity by Electroporation In Vivo. The Journal of Immunology. 164(9). 4635–4640. 445 indexed citations

14.

Dupuis, Marc, Kimberly Denis-Mize, Cheryl Goldbeck, et al.. (2000). Distribution of DNA Vaccines Determines Their Immunogenicity After Intramuscular Injection in Mice. The Journal of Immunology. 165(5). 2850–2858. 261 indexed citations

15.

Ni, Yongnian, Mark Selby, Serge Kokot, & M. C. Hodgkinson. (1993). Curve resolution and quantification of pyrazines by differential-pulse polarography using a Kalman filter approach. The Analyst. 118(8). 1049–1049. 15 indexed citations

16.

Spaete, Richard R., et al.. (1992). 5′ end-dependent translation initiation of hepatitis C viral RNA and the presence of putative positive and negative translational control elements within the 5′ untranslated region. Virology. 191(2). 889–899. 58 indexed citations

17.

Selby, Mark, et al.. (1989). End use markets for MSW compost.. Biocycle. 30(11). 56–58. 3 indexed citations

18.

Edwards, Robert H., Mark Selby, William C. Mobley, et al.. (1988). Processing and Secretion of Nerve Growth Factor: Expression in Mammalian Cells with a Vaccinia Virus Vector. Molecular and Cellular Biology. 8(6). 2456–2464. 29 indexed citations

19.

Moore, T. J. T., C. M. Mountain, T. Yamashita, & Mark Selby. (1988). New near-infrared sources and reflection nebulosity in W75N. Monthly Notices of the Royal Astronomical Society. 234(1). 95–105. 9 indexed citations

20.

Scott, James, Mickey S. Urdea, Margarita Quiroga, et al.. (1983). Structure of a Mouse Submaxillary Messenger RNA Encoding Epidermal Growth Factor and Seven Related Proteins. Science. 221(4607). 236–240. 392 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact